Sequencing depth determines how many reads support a measured proportion at a locus. A VAF calculated from limited coverage may be more vulnerable to the effect of individual reads, while deeper coverage supplies a larger read set for evaluating the same alternate-to-total relationship. Consequently, depth should accompany VAF interpretation rather than treating the fraction as independent of data quantity.
The measured fraction reflects the mixture of cells represented in the sequencing sample, not only the cells carrying the variant. If variant-bearing cells make up a smaller portion of the material, their reads can represent a smaller share of the total. Tumor purity therefore becomes important when interpreting VAF in samples containing both tumor and non-tumor cells.
Copy-number changes alter the genomic context in which a variant is measured. Because the alternate-allele proportion depends on the reads contributed by the relevant genomic copies, the same biological variant may produce different VAF patterns when copy number differs. VAF should therefore be interpreted alongside copy-number information rather than used alone to infer the abundance of variant-bearing cells.
First identify the alternate-allele read count and the total number of reads covering the genomic position, then calculate their ratio. Next, review sequencing depth, sample composition, tumor purity, copy-number changes, and possible technical errors. This workflow separates the numerical measurement from the biological interpretation and helps determine whether the observed value is informative for the study.
VAF patterns provide evidence about how broadly a variant is represented within a sample. A variant found across a larger population may show a different fraction from one restricted to a subclone, while mosaic variation reflects the presence of the variant in only some cells. These interpretations remain dependent on purity, copy number, depth, and technical reliability.
During variant calling, VAF helps describe how strongly sequencing data support a specific alternate allele at a genomic position. Comparing the fraction with read coverage and potential technical errors can also reveal whether an apparent signal is reliable or may reflect a problematic sample or measurement. Thus, VAF contributes both to identifying variants and to judging supporting data quality.
Repeated VAF measurements can show whether the representation of a variant changes across disease-related samples or during treatment monitoring. A rising or falling value may indicate a change in the population carrying that variant, although interpretation still requires attention to sample composition, tumor purity, copy-number changes, sequencing depth, and technical error.